Autoantibodies in type 1 diabetes

References

• Geiss LS, Pan L, Cadwell B, Gregg EW, Benjamin SM, Engelgau MM. Changes in incidence of diabetes in US adults, 1997–2003. Am J Prev Med 2006; 30: 371–377
   PubMed Web of Science ®Google Scholar
• Taplin CE, Craig ME, Lloyd M, Taylor C, Crock P, Silink M, et al. The rising incidence of childhood type 1 diabetes in New South Wales, 1990–2002. Med J Aust 2005; 183: 243–246
   PubMedGoogle Scholar
• Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, LaPorte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Care 2000; 23: 1516–1526, Diabetes Mondiale (DiaMond) Project Group
   PubMed Web of Science ®Google Scholar
• Haynes A, Bower C, Bulsara MK, Jones TW, Davis EA. Continued increase in the incidence of childhood type 1 diabetes in a population-based Australian sample (1985–2002). Diabetologia 2004; 47: 866–870
   PubMed Web of Science ®Google Scholar
• Engelgau MM, Geiss LS, Saaddine JB, Boyle JP, Benjamin SM, Gregg EW, et al. The evolving diabetes burden in the United States. Ann Intern Med 2004; 140: 945–950
   PubMed Web of Science ®Google Scholar
• Bruno G, Runzo C, Cavallo-Perin P, Merletti F, Rivetti M, Pinach S, et al. Incidence of type 1 and type 2 diabetes in adults aged 30–49 years: The population-based registry in the province of Turin, Italy. Diabetes Care 2005; 28: 2613–2619
   PubMedGoogle Scholar
• Eisenbarth GS. Type I diabetes mellitus. A chronic autoimmune disease. N Engl J Med 1986; 314: 1360–1368
   PubMed Web of Science ®Google Scholar
• Harjutsalo V, Reunanen A, Tuomilehto J. Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring. Diabetes 2006; 55: 1517–1524
   PubMed Web of Science ®Google Scholar
• Rich SS. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 1990; 39: 1315–1319
   PubMed Web of Science ®Google Scholar
• Tuomilehto J, Podar T, Tuomilehto-Wolf E, Virtala E. Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents. Diabetologia 1995; 38: 975–982
   PubMed Web of Science ®Google Scholar
• Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: A population based study of young Danish twins. BMJ 1995; 311: 913–917
   PubMed Web of Science ®Google Scholar
• Redondo MJ, Rewers M, Yu L, Garg S, Pilcher CC, Elliott RB, et al. Genetic determination of islet cell autoimmunity in monozygotic twin, dizygotic twin, an non-twin siblings of patients with type 1 diabetes: Prospective twin study. BMJ 1999; 318: 698–702
   PubMedGoogle Scholar
• Nerup J, Platz P, Andersen OO, Christy M, Lyngsoe J, Poulsen JE, et al. HL-A antigens and diabetes mellitus. Lancet 1974; 2: 864–866
   PubMed Web of Science ®Google Scholar
• Lambert AP, Gillespie KM, Thomson G, Cordell HJ, Todd JA, Gale EA, et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: A population-based study in the United Kingdom. J Clin Endocrinol Metab 2004; 89: 4037–4043
   PubMed Web of Science ®Google Scholar
• Barker JM, Barriga KJ, Yu L, Miao D, Erlich HA, Norris JM, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes autoimmunity study in the young (DAISY). J Clin Endocrinol Metab 2004; 89: 3896–3902
   PubMed Web of Science ®Google Scholar
• Bottazzo GF, Florin-Christensen A, Doniach D. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies. Lancet 1974; 2: 1279–1283
   PubMed Web of Science ®Google Scholar
• Yu L, Eisenbarth GS. Type 1 diabetes: molecular, cellular and clinical immunology. Humoral Autoimmunity. Online edition, 2 February 2007.
   Google Scholar
• Bonifacio E, Bingley PJ, Shattock M, Dean BM, Dunger D, Gale EA, et al. Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet 1990; 335: 147–149
   PubMed Web of Science ®Google Scholar
• Greenbaum CJ, Palmer JP, Kuglin B, Kolb H. Insulin autoantibodies measured by radioimmunoassay methodology are more related to insulin-dependent diabetes mellitus than those measured by enzyme-linked immunosorbent assay: Results of the Fourth International Workshop on the Standardization of Insulin Autoantibody Measurement. J Clin Endocrinol Metab 1992; 74: 1040–1044
   PubMedGoogle Scholar
• Berson SA, Yalow RS. Quantitative aspects of the reaction between insulin and insulin-binding antibody. J Clin Invest 1959; 38: 1996–2016
   PubMed Web of Science ®Google Scholar
• Palmer JP, Asplin CM, Clemons P, Lyen K, Tatpati O, Raghu PK, et al. Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 1983; 222: 1337–1339
   PubMed Web of Science ®Google Scholar
• Ziegler AG, Vardi P, Gross DJ, Bonner-Weir S, Villa-Komaroff L, Halban PA, et al. Production of insulin antibodies by mice rejecting insulin transfected cells. J Autoimmun 1989; 2: 219–227
   PubMedGoogle Scholar
• Pugliese A, Bugawan T, Moromisato R, Awdeh ZL, Alper CA, Jackson RA, et al. Two subsets of HLA-DQA1 alleles mark phenotypic variation in levels of insulin autoantibodies in first degree relatives at risk for insulin-dependent diabetes. J Clin Invest 1994; 93: 2447–2452
   PubMedGoogle Scholar
• Achenbach P, Koczwara K, Knopff A, Naserke H, Ziegler AG, Bonifacio E. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes. J Clin Invest 2004; 114: 589–597
   PubMedGoogle Scholar
• Payton MA, Hawkes CJ, Christie MR. Relationship of the 37,000- and 40,000-M(r) tryptic fragments of islet antigens in insulin-dependent diabetes to the protein tyrosine phosphatase-like molecule IA-2 (ICA512). J Clin Invest 1995; 96: 1506–1511
   PubMed Web of Science ®Google Scholar
• Boitard C, Bonifacio E, Bottazzo GF, Gleichmann H, Molenaar J. Immunology and Diabetes Workshop: Report on the Third International (Stage 3) Workshop on the standardisation of cytoplasmic islet cell antibodies. Diabetologia 1988; 31: 451–452, Held in New York, October 1987
   PubMedGoogle Scholar
• Bonifacio E, Boitard C, Gleichmann H, Shattock MA, Molenaar JL, Bottazzo GF. Assessment of precision, concordance, specificity, and sensitivity of islet cell antibody measurement in 41 assays. Diabetologia 1990; 33: 731–736
   PubMed Web of Science ®Google Scholar
• Bingley PJ, Bonifacio E, Mueller PW. Diabetes Antibody Standardization Program: First assay proficiency evaluation. Diabetes 2003; 52: 1128–1136
   PubMed Web of Science ®Google Scholar
• Achenbach P, Schlosser M, Williams AJ, Yu L, Mueller PW, Bingley PJ, et al. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program. 2007. Clinical Immunology 2007; 122: 85–90
   PubMedGoogle Scholar
• Li L, Hagopian WA, Brashear HR, Daniels T, Lernmark A. Identification of autoantibody epitopes of glutamic acid decarboxylase in stiff-man syndrome patients. J Immunol 1994; 152: 930–934
   PubMed Web of Science ®Google Scholar
• Nejentsev S, Sjoroos M, Soukka T, Knip M, Simell O, Lovgren T, et al. Population-based genetic screening for the estimation of type 1 diabetes mellitus risk in Finland: Selective genotyping of markers in the HLA-DQB1, HLA-DQA1 and HLA-DRB1 loci. Diabet Med 1999; 16: 985–992
   PubMedGoogle Scholar
• Ziegler AG, Hummel M, Schenker M, Bonifacio E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: The 2-year analysis of the German BABYDIAB Study. Diabetes 1999; 48: 460–468
   PubMed Web of Science ®Google Scholar
• Yu L, Rewers M, Gianani R, Kawasaki E, Zhang Y, Verge C, et al. Antiislet autoantibodies usually develop sequentially rather than simultaneously. J Clin Endocrinol Metab 1996; 81: 4264–4267
   PubMed Web of Science ®Google Scholar
• Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase HP, et al. Number of autoantibodies (against insulin, GAD or ICA512/IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun 1996; 9: 379–383
   PubMed Web of Science ®Google Scholar
• Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Jackson RA, et al. Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc/IA-2 autoantibodies. Diabetes 1996; 45: 926–933
   PubMed Web of Science ®Google Scholar
• Achenbach P, Warncke K, Reiter J, Naserke HE, Williams AJ, Bingley PJ, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics. Diabetes 2004; 53: 384–392
   PubMed Web of Science ®Google Scholar
• Keskinen P, Korhonen S, Kupila A, Veijola R, Erkkila S, Savolainen H, et al. First-phase insulin response in young healthy children at genetic and immunological risk for type I diabetes. Diabetologia 2002; 45: 1639–1648
   PubMed Web of Science ®Google Scholar
• Koczwara K, Bonifacio E, Ziegler AG. Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes. Diabetes 2004; 53: 1–4
   PubMed Web of Science ®Google Scholar
• Martin S, Wolf-Eichbaum D, Duinkerken G, Scherbaum WA, Kolb H, Noordzij JG, et al. Development of type 1 diabetes despite severe hereditary B lymphocyte deficiency. N Engl J Med 2001; 345: 1036–1040
   PubMed Web of Science ®Google Scholar
• Umpierrez GE, Latif KA, Murphy MB, Lambeth HC, Stentz F, Bush A, et al. Thyroid dysfunction in patients with type 1 diabetes: A longitudinal study. Diabetes Care 2003; 26: 1181–1185
   PubMed Web of Science ®Google Scholar
• Barker JM, Yu J, Yu L, Wang J, Miao D, Bao F, et al. Autoantibody “subspecificity” in type 1 diabetes: Risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 2005; 28: 850–855
   PubMed Web of Science ®Google Scholar
• Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C, et al. Younger age at onset and sex predict celiac disease in children and adolescents with type 1 diabetes: An Italian multicenter study. Diabetes Care 2004; 27: 1294–1298
   PubMed Web of Science ®Google Scholar
• Yu L, Brewer KW, Gates S, Wu A, Wang T, Babu SR, et al. DRB1*04 and DQ alleles: Expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999; 84: 328–335
   PubMed Web of Science ®Google Scholar
• Betterle C, Scalici C, Presotto F, Pedini B, Moro L, Rigon F, et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988; 117: 467–475
   PubMed Web of Science ®Google Scholar
• Betterle C, Volpato M, Rees SB, Furmaniak J, Chen S, Zanchetta R, et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ specific autoimmune diseases: Markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82: 939–942
   PubMed Web of Science ®Google Scholar